Clinical trial

Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00403845

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-12-01

PhasePHASE2

Study timeline

Study start (unknown)2006-12-01Date precision: month

Registry last updated2011-08-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

Indacaterol 150 μgDRUG

Indacaterol 300 μgDRUG

PlaceboDRUG

Sponsors & collaborators

Novartislead sponsor

Mapped research locations

TokyoJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00403845 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.